Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants
Abstract Epstein-Barr virus (EBV) infects greater than 90% of humans, is recognized as a significant comorbidity with HIV/AIDS, and is an etiologic agent for some human cancers. The critically endangered mountain gorilla population was suspected of infection with an EBV-like virus based on serology...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/115a8af1cbd34684976338917d009654 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:115a8af1cbd34684976338917d009654 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:115a8af1cbd34684976338917d0096542021-12-02T15:06:18ZMountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants10.1038/s41598-017-04877-12045-2322https://doaj.org/article/115a8af1cbd34684976338917d0096542017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04877-1https://doaj.org/toc/2045-2322Abstract Epstein-Barr virus (EBV) infects greater than 90% of humans, is recognized as a significant comorbidity with HIV/AIDS, and is an etiologic agent for some human cancers. The critically endangered mountain gorilla population was suspected of infection with an EBV-like virus based on serology and infant histopathology similar to pulmonary reactive lymphoid hyperplasia (PRLH), a condition associated with EBV in HIV-infected children. To further examine the presence of EBV or an EBV-like virus in mountain gorillas, we conducted the first population-wide survey of oral samples for an EBV-like virus in a nonhuman great ape. We discovered that mountain gorillas are widely infected (n = 143/332) with a specific strain of lymphocryptovirus 1 (GbbLCV-1). Fifty-two percent of infant mountain gorillas were orally shedding GbbLCV-1, suggesting primary infection during this stage of life, similar to what is seen in humans in less developed countries. We then identified GbbLCV-1 in post-mortem infant lung tissues demonstrating histopathological lesions consistent with PRLH, suggesting primary infection with GbbLCV-1 is associated with PRLH in infants. Together, our findings demonstrate that mountain gorilla’s infection with GbbLCV-1 could provide valuable information for human disease in a natural great ape setting and have potential conservation implications in this critically endangered species.Tierra Smiley EvansLinda J. LowenstineKirsten V. GilardiPeter A. BarryBenard J. SsebideJean Felix KinaniFred NizeyimanaJean Bosco NoheriMichael R. CranfieldAntoine MudakikwaTracey GoldsteinJonna A. K. MazetChristine Kreuder JohnsonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Tierra Smiley Evans Linda J. Lowenstine Kirsten V. Gilardi Peter A. Barry Benard J. Ssebide Jean Felix Kinani Fred Nizeyimana Jean Bosco Noheri Michael R. Cranfield Antoine Mudakikwa Tracey Goldstein Jonna A. K. Mazet Christine Kreuder Johnson Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants |
description |
Abstract Epstein-Barr virus (EBV) infects greater than 90% of humans, is recognized as a significant comorbidity with HIV/AIDS, and is an etiologic agent for some human cancers. The critically endangered mountain gorilla population was suspected of infection with an EBV-like virus based on serology and infant histopathology similar to pulmonary reactive lymphoid hyperplasia (PRLH), a condition associated with EBV in HIV-infected children. To further examine the presence of EBV or an EBV-like virus in mountain gorillas, we conducted the first population-wide survey of oral samples for an EBV-like virus in a nonhuman great ape. We discovered that mountain gorillas are widely infected (n = 143/332) with a specific strain of lymphocryptovirus 1 (GbbLCV-1). Fifty-two percent of infant mountain gorillas were orally shedding GbbLCV-1, suggesting primary infection during this stage of life, similar to what is seen in humans in less developed countries. We then identified GbbLCV-1 in post-mortem infant lung tissues demonstrating histopathological lesions consistent with PRLH, suggesting primary infection with GbbLCV-1 is associated with PRLH in infants. Together, our findings demonstrate that mountain gorilla’s infection with GbbLCV-1 could provide valuable information for human disease in a natural great ape setting and have potential conservation implications in this critically endangered species. |
format |
article |
author |
Tierra Smiley Evans Linda J. Lowenstine Kirsten V. Gilardi Peter A. Barry Benard J. Ssebide Jean Felix Kinani Fred Nizeyimana Jean Bosco Noheri Michael R. Cranfield Antoine Mudakikwa Tracey Goldstein Jonna A. K. Mazet Christine Kreuder Johnson |
author_facet |
Tierra Smiley Evans Linda J. Lowenstine Kirsten V. Gilardi Peter A. Barry Benard J. Ssebide Jean Felix Kinani Fred Nizeyimana Jean Bosco Noheri Michael R. Cranfield Antoine Mudakikwa Tracey Goldstein Jonna A. K. Mazet Christine Kreuder Johnson |
author_sort |
Tierra Smiley Evans |
title |
Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants |
title_short |
Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants |
title_full |
Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants |
title_fullStr |
Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants |
title_full_unstemmed |
Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants |
title_sort |
mountain gorilla lymphocryptovirus has epstein-barr virus-like epidemiology and pathology in infants |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/115a8af1cbd34684976338917d009654 |
work_keys_str_mv |
AT tierrasmileyevans mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants AT lindajlowenstine mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants AT kirstenvgilardi mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants AT peterabarry mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants AT benardjssebide mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants AT jeanfelixkinani mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants AT frednizeyimana mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants AT jeanbosconoheri mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants AT michaelrcranfield mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants AT antoinemudakikwa mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants AT traceygoldstein mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants AT jonnaakmazet mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants AT christinekreuderjohnson mountaingorillalymphocryptovirushasepsteinbarrviruslikeepidemiologyandpathologyininfants |
_version_ |
1718388496597516288 |